×
验证码:
换一张
忘记密码?
记住我
CORC
首页
科研机构
检索
知识图谱
申请加入
托管服务
登录
注册
在结果中检索
科研机构
合肥物质科学研究院 [10]
理论物理研究所 [1]
内容类型
期刊论文 [11]
发表日期
2022 [11]
学科主题
Optics [1]
Physics [1]
×
知识图谱
CORC
开始提交
已提交作品
待认领作品
已认领作品
未提交全文
收藏管理
QQ客服
官方微博
反馈留言
浏览/检索结果:
共11条,第1-10条
帮助
限定条件
发表日期:2022
已选(
0
)
清除
条数/页:
5
10
15
20
25
30
35
40
45
50
55
60
65
70
75
80
85
90
95
100
排序方式:
请选择
发表日期升序
发表日期降序
提交时间升序
提交时间降序
题名升序
题名降序
作者升序
作者降序
Analysis of the efficacy and safety of immunotherapy in advanced thymoma patients
期刊论文
CANCER MEDICINE, 2022
作者:
Hao, Yue
;
Lin, Gen
;
Xiang, Jing
;
Wang, Wenxian
;
Xu, Chunwei
收藏
  |  
浏览/下载:15/0
  |  
提交时间:2022/12/23
efficacy
immune-related adverse events
immunotherapy
thymoma
Chinese expert consensus on the multidisciplinary management of pneumonitis associated with immune checkpoint inhibitor
期刊论文
THORACIC CANCER, 2022
作者:
Wang, Wenxian
;
Wang, Qian
;
Xu, Chunwei
;
Li, Ziming
;
Song, Zhengbo
收藏
  |  
浏览/下载:29/0
  |  
提交时间:2022/12/23
checkpoint inhibitor pneumonitis
Chinese experts consensus
immune checkpoint inhibitor-related adverse effects
Treatment outcomes and prognosis of immune checkpoint inhibitors therapy in patients with advanced thymic carcinoma: A multicentre retrospective study
期刊论文
EUROPEAN JOURNAL OF CANCER, 2022, 卷号: 174
作者:
Wang, Wenxian
;
Lin, Gen
;
Guan, Yelan
;
Zhang, Yuxin
;
Xu, Chunwei
收藏
  |  
浏览/下载:18/0
  |  
提交时间:2022/12/23
Thymic carcinoma
Immunotherapy
PD-1
Efficacy
Immune-related adverse events
Expert consensus on the diagnosis and treatment of NTRK gene fusion solid tumors in China
期刊论文
THORACIC CANCER, 2022
作者:
Xu, Chunwei
;
Si, Lu
;
Wang, Wenxian
;
Li, Ziming
;
Song, Zhengbo
收藏
  |  
浏览/下载:33/0
  |  
提交时间:2022/12/22
fusion
precision medicine
solid tumor
targeted therapy
tyrosine receptor kinase
DNA methylation profiling to determine the primary sites of metastatic cancers using formalin-fixed paraffin-embedded tissues.
期刊论文
JOURNAL OF CLINICAL ONCOLOGY, 2022, 卷号: 40
作者:
Gu, Hongcang
;
Zhang, Shirong
;
He, Shutao
;
Zhu, Xin
;
Wang, Yunfei
收藏
  |  
浏览/下载:6/0
  |  
提交时间:2022/12/23
Apatinib in patients with recurrent or metastatic thymic epithelial tumor: a single-arm, multicenter, open-label, phase II trial
期刊论文
BMC MEDICINE, 2022, 卷号: 20
作者:
Song, Zhengbo
;
Lou, Guangyuan
;
Wang, Yina
;
Yang, Zhiping
;
Wang, Wenxian
收藏
  |  
浏览/下载:14/0
  |  
提交时间:2022/12/23
Thymic epithelial tumors
Apatinib
Efficacy
Toxicities
Efficacy and safety of anlotinib with and without EGFR-TKIs or immunotherapy in the treatment of elder patients with non-small-cell lung cancer: a retrospective study
期刊论文
BMC PULMONARY MEDICINE, 2022, 卷号: 22
作者:
Wang, Wenxian
;
Shao, Lan
;
Xu, Yibing
;
Song, Zhengbo
;
Lou, Guangyuan
收藏
  |  
浏览/下载:14/0
  |  
提交时间:2022/12/23
Non-small cell lung cancer
Prognosis
Angiogenesis
Tyrosine kinase inhibitors
Novel HIVEP1-ALK fusion in a patient with lung adenocarcinoma demonstrating sensitivity to alectinib: a case report
期刊论文
TRANSLATIONAL LUNG CANCER RESEARCH, 2022, 卷号: 11
作者:
Gu, Xiaodong
;
Wang, Wenxian
;
Wu, Wei
;
Zhang, Yiping
;
Shao, Lan
收藏
  |  
浏览/下载:12/0
  |  
提交时间:2022/12/22
Non-small cell lung cancer (NSCLC)
HIVEP1-ALK
alectinib
intergenic region (IGR)
case report
Treatment outcomes and prognosis of patients with primary and acquired BRAF-mutated non-small cell lung cancer: A multicenter retrospective study
期刊论文
GENES CHROMOSOMES & CANCER, 2022
作者:
Wang, Wenxian
;
Gu, Xiaodong
;
Si, Jinfei
;
Pu, Xingxiang
;
Wang, Liping
收藏
  |  
浏览/下载:31/0
  |  
提交时间:2022/05/16
BRAF mutation
immune checkpoint inhibitors
non-small cell lung cancer
PD-L1
targeted therapy
Disease progression patterns and molecular resistance mechanisms to crizotinib of lung adenocarcinoma harboring ROS1 rearrangements
期刊论文
NPJ PRECISION ONCOLOGY, 2022, 卷号: 6
作者:
Zhang, Yongchang
;
Huang, Zhe
;
Zeng, Liang
;
Zhang, Xiangyu
;
Li, Yizhi
收藏
  |  
浏览/下载:20/0
  |  
提交时间:2022/05/05
©版权所有 ©2017 CSpace - Powered by
CSpace